Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


India Satisfied With Change In WHO Counterfeit Drug Definition

This article was originally published in PharmAsia News

Executive Summary

Indian authorities appear to have put to rest fears the products of Indian drug makers would be labeled counterfeit under a new UN agency rule. The World Health Organization-funded agency had proposed a definition that would have identified counterfeits as those with a "false representation about their identity, history or source." Indian representatives argued at the WHO such a definition could include legitimate generics. Surinder Singh, the Drug Controller General of India, said the WHO has agreed to drop the word "history" from the definition, addressing a major Indian complaint, but that intellectual property right and trademark issues remain problems for the government. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts